GLP-1 receptor agonist lixisenatide protects against high free fatty acids-induced oxidative stress and inflammatory response

Exenatide exhibits anti-inflammatory properties and modulates endothelial response to tumor necrosis factor α-mediated activation

(2018) Wojciech Garczorz et al.   Cardiovascular Therapeutics

Netrin-1 prevents the attachment of monocytes to endothelial cells via an anti-inflammatory effect

(2018) Zhaoheng Lin et al.   MOLECULAR IMMUNOLOGY

Exenatide exerts direct protective effects on endothelial cells through the AMPK/Akt/eNOS pathway in a GLP-1 receptor-dependent manner

(2016) Rui Wei et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Exenatide Protects Against Glucose- and Lipid-Induced Endothelial Dysfunction: Evidence for Direct Vasodilation Effect of GLP-1 Receptor Agonists in Humans

(2015) Juraj Koska et al.   DIABETES

Exendin-4 alleviates retinal vascular leakage by protecting the blood–retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats

(2014) Yichao Fan et al.   EXPERIMENTAL EYE RESEARCH

Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2014) Marie Ng et al.   LANCET

Exendin-4 inhibits endothelial protein C receptor shedding in vitro and in vivo

(2014) Sae-Kwang Ku et al.   PHARMACOLOGICAL RESEARCH

Uncoupling Protein-2 Mediates DPP-4 Inhibitor-Induced Restoration of Endothelial Function in Hypertension Through Reducing Oxidative Stress

(2013) Limei Liu et al.   ANTIOXIDANTS & REDOX SIGNALING

Pharmacological profile, efficacy and safety of lixisenatide in type 2 diabetes mellitus

(2013) Thomas Forst et al.   EXPERT OPINION ON PHARMACOTHERAPY

Dipeptidyl Peptidase 4 Inhibitor Sitagliptin Protects Endothelial Function in Hypertension Through a Glucagon–Like Peptide 1–Dependent Mechanism

(2012) Limei Liu et al.   HYPERTENSION

LDL Apheresis and Inflammation - Implications for Atherosclerosis

(2012) A. Hovland et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-/- mouse model

(2011) Tracey Gaspari et al.   Diabetes & Vascular Disease Research

Glucagon-Like Peptide-1 and Diabetes

(2011) Matteo Monami   Experimental Diabetes Research

RETRACTED ARTICLE: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells

(2010) Y. Hattori et al.   DIABETOLOGIA

Effects of Exenatide on Systolic Blood Pressure in Subjects With Type 2 Diabetes

(2009) T. Okerson et al.   AMERICAN JOURNAL OF HYPERTENSION

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

(2008) Kiwon Ban et al.   CIRCULATION